Li, Y., Dai, C., Yang, H., Zeng, H., Ruan, Y., Dai, M., . . . Ji, F. (2024). Cross‐sectional and Mendelian randomization study of fibroblast growth factor 19 reveals causal associations with metabolic diseases. Journal of gastroenterology and hepatology, 39(12), 2872-2879. https://doi.org/10.1111/jgh.16687
Chicago-Zitierstil (17. Ausg.)Li, Yan, et al. "Cross‐sectional and Mendelian Randomization Study of Fibroblast Growth Factor 19 Reveals Causal Associations with Metabolic Diseases." Journal of Gastroenterology and Hepatology 39, no. 12 (2024): 2872-2879. https://doi.org/10.1111/jgh.16687.
MLA-Zitierstil (9. Ausg.)Li, Yan, et al. "Cross‐sectional and Mendelian Randomization Study of Fibroblast Growth Factor 19 Reveals Causal Associations with Metabolic Diseases." Journal of Gastroenterology and Hepatology, vol. 39, no. 12, 2024, pp. 2872-2879, https://doi.org/10.1111/jgh.16687.